HFE and metabolic dysfunction-associated steatotic liver disease: These findings led us to consider whether a partial deficiency of functional HFE, as seen in those with heterozygous C282Y and H63D mutations, might be sufficient to dysregulate hepatic lipid metabolism and promote liver injury in NAFLD.